DisneyA.Australia and New Zealand Dialysis and Transplantation Registry, 1991.
2.
GrundyS.M.Cholesterol and coronary heart disease. A new era.JAMA1986; 256: 2849–58.
3.
HolmeI.An analysis of randomized trials evaluating the effects of cholesterol reduction on total mortality and coronary heart disease incidence.Circulation1990; 82: 1916–24.
4.
MuldoonM.F., ManuckS.B., MathewsK.A.Lowering cholesterol concentrations and mortality: A quantitative review of primary prevention trials.Br Med J1990; 301: 309–14.
5.
GrundyS.M.Management of hyperlipidaemia of kidney disease.Kidney Int1990; 37: 847–53.
6.
AttmanP.O., AlavpovicP.Lipid abnormalities in chronic renal insufficiency.Kidney Int1991; 39: 516–23.
7.
IrishA.B., SimonsL.A., SavdieE., HayesJ.M., SimonsJ.Lipoprotein (a) levels in chronic renal disease states, dialysis and transplantation.Aust NZ J Med1992; 22: 243–8.
8.
TetsuoS., NishizawaY., NishitaniH., YamakawaM., MoriiH.Impaired metabolism of high density lipoprotein in uremic patients.Kidney Int1992; 41: 1653–61.
9.
BurrellD., AntignaniA., FeinP.A., GoldwasserP., MittmanN., AvramM.M.Longitudinal survey of apolipoproteinB and atherogenic risk in hemodialysis and continuous ambulatory peritoneal dialysis patients.ASAIO Trans1990; 36(3): M331–5.
10.
Di PaoloB., Del RossoG., CatucciG.Therapeutic effects of simvastatin on hyperlipidemia in CAPD patients.ASAIO Trans1990; 36(3): M578–80.
11.
ThomasM.E., MoorheadJ.F.Lipids in CAPD: A review.Contrib Nephrol1990; 85: 92–9.
12.
GahlG.M., HainH.Nutrition and metabolism in con tinuous ambulatory peritoneal dialysis.Contrib Nephrol1990; 84: 36–44.
13.
ChanM.K.Sustained-release bezafibrate corrects lipid abnormalities in patients on continuous ambulatory peritoneal dialysis.Nephron1990; 56: 56–61.
WebbA.T., BrownE.A.Lipoprotein (a) in patients on peritoneal dialysis (Abstract).Perit Dial Int1992; 12(Suppl 2): 870.
16.
LaiK.N., MakG., MakT.Effect oflovastatin on the lipid profiles in uremic patients on CAPD (Abstract).Perit Dial Int1992; 12(Suppl 2): S70.
17.
CocciR., Degli EspostiE., FabbriA., LucatelloA., StoraniA., FosaroliM.Long-term treatment with sustained-release bezafibrate (8RB) in patients on CAPD (Abstract).Perit Dial Int1992; 12(Suppl 2): S71.
18.
FracassoA., ToffolettoP.P., BazzatoG.Effect of hypertriglyceridemia correction by omega -3 fatty acids on peritoneal transport in CAPD patients (Abstract).Perit Dial Int1992; 12(Suppl 2): 877.
